• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION BLAZER II HTD; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION BLAZER II HTD; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Model Number 85056
Medical Device Problem Code Temperature Problem (3022)
Health Effect - Clinical Code Swelling/ Edema (4577)
Date of Event 07/16/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event or Problem Description
During an ablation procedure to treat supraventricular tachycardia a blazer ii htd catheter was selected for use.It was reported that the temperature did not meet the ablation requirements of the lesion.Repeated ablation attempts resulted in edema on the contact surface of the lesion."emergency treatment" might have been performed to treat the edema, however the details are unknown.The procedure was cancelled and rescheduled.No additional complications were reported and the patient's current condition is fine.
 
Additional Manufacturer Narrative
The device was received by boston scientific for analysis.Upon product analysis it was observed that the continuity test was performed, and the device was found within specifications.No opens or shorts were found.The ablation was verified by using the maestro generator 4000, and the device was found within specifications.Based on the information provided, there is no evidence that the device was used in a manner inconsistent with the labelled indications/instructions for use (ifu).The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.
 
Event or Problem Description
During an ablation procedure to treat supraventricular tachycardia a blazer ii htd catheter was selected for use.It was reported that the temperature did not meet the ablation requirements of the lesion.Repeated ablation attempts resulted in edema on the contact surface of the lesion."emergency treatment" might have been performed to treat the edema, however the details are unknown.The procedure was cancelled and rescheduled.No additional complications were reported and the patient's current condition is fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BLAZER II HTD
Common Device Name
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
302 parkway, global park
la aurora - heredia
CS  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key12590986
Report Number2134265-2021-12346
Device Sequence Number4380473
Product Code LPB
UDI-Device Identifier08714729172048
UDI-Public08714729172048
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
P920047
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date05/21/2022
Device Model Number85056
Device Catalogue Number85056
Device Lot Number0023838648
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/07/2021
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 09/16/2021
Supplement Date Received by Manufacturer10/22/2021
Initial Report FDA Received Date10/07/2021
Supplement Report FDA Received Date11/10/2021
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/22/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age50 YR
Patient SexMale
Patient Weight60 KG
-
-